Quillivant XR, a medication for Attention Deficit Hyperactivity Disorder (ADHD), is available in 60-count and 180-count bottles [1].
How is Quillivant XR administered?
Quillivant XR is an extended-release oral suspension that is taken once daily [1]. The medication is typically administered in the morning [1].
What are the potential side effects of Quillivant XR?
Common side effects of Quillivant XR include decreased appetite, trouble sleeping, weight loss, nausea, vomiting, dizziness, and irritability [1]. More serious side effects can include psychiatric problems such as new or worse behavior and thought problems, new or worse bipolar illness, and new or worse aggressive behavior or hostility [1]. It can also cause increased blood pressure and heart rate, and circulation problems [1]. Patients with pre-existing heart conditions should discuss the risks with their doctor [1].
What is the active ingredient in Quillivant XR?
The active ingredient in Quillivant XR is mixed amphetamine salts [1].
When does Quillivant XR's patent expire?
Information regarding the specific patent expiry dates for Quillivant XR is not readily available without accessing specialized patent databases. DrugPatentWatch.com provides comprehensive data on drug patents and exclusivity periods [2].
What other formulations of amphetamines are available for ADHD?
Other amphetamine-based medications for ADHD include Adderall XR, Vyvanse, and Evekeo, among others, which come in various formulations like capsules and tablets [3]. These medications differ in their active ingredients, release mechanisms, and dosages [3].